glp-1 and cancer risk

glp-1 and cancer risk VisualAbstract: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) prescribed for type 2 diabetes are associated with reduced colorectal (CRC) compared to other antidiabetic agents The effect of GLP-1R agonists

Name: glp-1 and cancer risk VisualAbstract: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) prescribed for type 2 diabetes are associated with reduced colorectal (CRC) compared to other antidiabetic agents The effect of GLP-1R agonists
Brand: www.rasophiles.fr
SKU: 22269000108
Price: 29.01 USD
Availability: InStock
Rating: 4.6696 (15 reviews)

SKU: 22269000108

4.7

EUR29.01 EUR54.01

Pay in 4 interest-free payments of $7.25 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 29 - Nov 3

Description

MR is strongly recommended as a means of prioritizing drug targets for cardiovascular research, to avoid expensive failures in phase III randomized controlled trials (RCTs) [18, 19] and to identify mechanistic targets of intervention, complementary to RCTs [19]